8-K current report · filed Oct 16, 2026

OCULAR THERAPEUTIX, INC (OCUL) 8-K Current Report: October 16, 2026

Item 5.02OCUL overview

Short answer

OCULAR THERAPEUTIX, INC (OCUL) filed an 8-K current report with the SEC on October 16, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Chief Strategy Officer Sanjay Nayak resigning effective October 16, 2026.

OCULAR THERAPEUTIX, INC 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Chief Strategy Officer Sanjay Nayak resigning effective October 16, 2026
  • Departure to become CEO of a privately held company, indicating loss of senior strategic leadership
  • No successor or transition arrangements identified in the filing

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other OCULAR THERAPEUTIX, INC 8-K filings

Get the next OCUL 8-K as it lands

Follow OCUL for push alerts, or ask the research agent what this filing means.